Live Long Walk Strong (LLWS) Rehabilitation Program: What Features Improve Mobility Skills (LLWS)

February 2, 2026 updated by: VA Office of Research and Development

The Live Long Walk Strong Rehabilitation Program: What Features Improve Mobility Skills?

This study was performed to evaluate the efficacy of the Live Long Walk Strong rehabilitation program in Veterans 50 years and older. This study will examine the features of the program that contribute to improved gait speed.

Study Overview

Status

Completed

Conditions

Detailed Description

This study was a 4 year phase II randomized clinical trial study design. This study will provide important information about the mechanisms that contribute to meaningful improvement in mobility, the benefits of a novel mode of physical therapy care, and the duration of treatment effect.

This study addresses Veterans with slow gait speed beginning in midlife. Slow walking speed is a major health concern for aging Veterans, that independent of disease status, predicts adverse health outcomes. Physical therapy (PT) care is the foundational treatment for slow gait speed, but no standard treatment approach exists. Clinically feasible modes of PT care that provide longer term improvements in gait speed are not established. The investigators developed Live Long Walk Strong , which is a clinically feasible program of PT care that builds upon research identifying novel modes of treatment with greater efficacy than standard care. The investigators have shown proof of concept among civilians and must confirm this among Veterans across a broader age range than was studied previously. Also, it is critical that the investigators define the attributes targeted by which LLWS induces gait speed improvements, not only after treatment ends but after 16 weeks of subsequent follow up. If successful, it will lead to LLWS refinements, establishing it as a rigorously tested model of PT care, that can be implemented across the VHA nationally.

Study Type

Interventional

Enrollment (Actual)

151

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Massachusetts
      • Boston, Massachusetts, United States, 02130-4817
        • VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

50 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Veteran
  • Aged 50 and older
  • Community dwelling
  • Ability to speak and understand English
  • Usual gait speed 0.5 m/s- 1.0 m/s Activity modifications and access to telehealth rehabilitation

Exclusion Criteria:

  • Presence of a terminal disease
  • A major medical problem, unstable chronic condition, or psychiatric disorder that interferes with safe and successful testing and training
  • Myocardial infarction or major surgery in previous 3 months
  • Planned major surgery
  • Baseline short physical performance battery score less than 4
  • Use of a walker
  • Modified mini mental status examination score less than or equal to 77
  • Presence of a significant disease specific impairment such as:

    • peripheral neurologic impairment
    • orthopedic impairment
    • visual impairment

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Live Long Walk Strong
8 week rehabilitation program
Live Long Walk Strong is a rehabilitation program that focuses on impairments known to contribute to mobility decline that are not considered standard of care in rehab and addresses behavioral change within the context of rehabilitation.
Active Comparator: 8 week wait list control
8 week wait list then followed by 8 weeks of the Live Long Walk Strong rehabilitation program
Live Long Walk Strong is a rehabilitation program that focuses on impairments known to contribute to mobility decline that are not considered standard of care in rehab and addresses behavioral change within the context of rehabilitation.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Walking Speed
Time Frame: Randomization to 8 weeks (comparing intervention to wait list)
Walking (gait) speed is assessed as usual walking pace over a 4-meter course.
Randomization to 8 weeks (comparing intervention to wait list)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Lower Extremity Power
Time Frame: Randomization to 8 weeks (comparing intervention to wait list groups)
Lower extremity power measure will be assessed via the modified stair climb test.
Randomization to 8 weeks (comparing intervention to wait list groups)
Trunk Muscle Endurance
Time Frame: Randomization to 8 weeks (comparing intervention to wait list groups)
Trunk muscle endurance will be assessed via saunders table through time (seconds) held in a fixed position of trunk extension. Position is held up to 2 minutes and 30 seconds (150 seconds total). The data presented is normalized by body weight.
Randomization to 8 weeks (comparing intervention to wait list groups)
Gait Variability
Time Frame: Randomization to 8 weeks (comparing intervention to wait list groups)
Gait variability will be assessed via zeno gait mat measurement of step length, step width and other measures of gait quality captured via the pkmas software within the zeno gait mat. Gait variability is reported as the standard deviation of stance time variability (SD), the standard deviation of stance time standard deviation. This measures the variability of static position within the gait cycle.
Randomization to 8 weeks (comparing intervention to wait list groups)

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Cognition - Delis-Kaplan Executive Function Systems (DKEFS) Verbal Fluency
Time Frame: Randomization to 8 weeks (comparing intervention to wait list groups)

A cognitive battery, including the DKEFS verbal fluency will be assessed pre and post intervention (within 2 weeks). Raw scores are used for each sub-test. The mean change in the raw score over the 8 weeks is reported.

  • Verbal Fluency: Letter Fluency total subscale score 6-83, with higher scores indicating a better outcome.
  • Verbal Fluency: Category Fluency total subscale score 17-63, with higher scores indicating a better outcome.
  • Verbal Fluency: Category Switching total subscale score 2-20, with higher scores indicating a better outcome.
  • Verbal Fluency: Category Switching total subscale score 1-21, with higher scores indicating a better outcome.
Randomization to 8 weeks (comparing intervention to wait list groups)
Cognition- DKEFS Trail Making Test
Time Frame: Randomization to 8 weeks (comparing intervention to wait list)
The DKEFS Trail Making Test used conditions 2 and 4. Time to complete was used to calculate the mean change over the 8-weeks. Mean change in time to complete each condition are reported.
Randomization to 8 weeks (comparing intervention to wait list)
Adherence
Time Frame: Intervention Period (8-weeks)
Adherence will be assessed by drop out status during the intervention period for each group respectively. This will be scored as a yes or no variable.
Intervention Period (8-weeks)
Compliance
Time Frame: Intervention Period (8-weeks)
Compliance with be assessed by the number of intervention sessions attended (out of 10).
Intervention Period (8-weeks)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Jonathan F. Bean, MD, VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 21, 2021

Primary Completion (Actual)

September 30, 2024

Study Completion (Actual)

November 7, 2024

Study Registration Dates

First Submitted

July 18, 2019

First Submitted That Met QC Criteria

July 18, 2019

First Posted (Actual)

July 19, 2019

Study Record Updates

Last Update Posted (Actual)

February 20, 2026

Last Update Submitted That Met QC Criteria

February 2, 2026

Last Verified

February 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • E3095-R

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Mobility Limitation

Clinical Trials on Live Long Walk Strong rehabilitation program

Subscribe